Organon Opens REMS Program for MIUDELLA Ahead of Anticipated Commercial Availability
Business Wire (Tue, 11-Aug 7:30 AM ET)
Organon Announces Quarterly Dividend
Business Wire (Fri, 31-Jul 8:30 AM ET)
Business Wire (Fri, 24-Jul 8:00 AM ET)
ORGANON CANADA ANNOUNCES THE APPOINTMENT OF DOMINIC BGIN AS PRESIDENT AND MANAGING DIRECTOR
PRNewswire (Wed, 22-Jul 8:02 AM ET)
Organon to Report Second Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing
Business Wire (Thu, 16-Jul 7:30 AM ET)
Business Wire (Tue, 7-Jul 8:00 AM ET)
Are TBRG, OGN, MDV Obtaining Fair Deals for their Shareholders?
PRNewswire (Thu, 25-Jun 1:58 PM ET)
Business Wire (Wed, 24-Jun 2:28 PM ET)
Business Wire (Tue, 23-Jun 5:30 AM ET)
Business Wire (Mon, 22-Jun 7:30 AM ET)
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Organon & Co. Common trades on the NYSE stock market under the symbol OGN.
As of August 13, 2026, OGN stock price climbed to $13.72 with 1,984,781 million shares trading.
OGN has a beta of 2.15, meaning it tends to be more sensitive to market movements. OGN has a correlation of 0.16 to the broad based SPY ETF.
OGN has a market cap of $3.60 billion. This is considered a Mid Cap stock.
Last quarter Organon & Co. Common reported $2 billion in Revenue and $.85 earnings per share. This beat revenue expectation by $5 million and missed earnings estimates by -$.18.
In the last 3 years, OGN traded as high as $23.37 and as low as $5.69.
The top ETF exchange traded funds that OGN belongs to (by Net Assets): IJR, VTI, VB, VBR, VXF.
OGN has outperformed the market in the last year with a return of +52.5%, while the SPY ETF gained +22.2%. However, in the most recent history, OGN shares have underperformed the stock market with its stock returning +3.1% in the last 3 month period and +1.3% for the last 2 week period, while SPY has returned +5.6% and +6.6%, respectively.
OGN support price is $13.63 and resistance is $13.69 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OGN shares will trade within this expected range on the day.